Coya Therapeutics COYA
NASDAQ COYA
$4.14 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Coya Therapeutics (COYA) Convertible Debt (2022)

Updated

Coya Therapeutics' Convertible Debt came in at $12.97 million for Q4 2022.

Analysis

Coya Therapeutics (COYA) Convertible Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Coya Therapeutics 98.99 Mn -69.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 12.97 Mn
API Access

Coya Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=COYA&period=max&api_key=YOUR_API_KEY